Absence of influence of prior interferon alfa (IFN alpha) therapy on the outcome of allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML).

被引：0
|
作者：
Tomas, IF [1 ]
Steegman, IL [1 ]
Requena, MI [1 ]
Soria, VGG [1 ]
FernandezRanada, IM [1 ]
机构：
[1] UNIV MADRID,HOSP PRINCESA,DEPT HAEMATOL,MADRID,SPAIN
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3859 / 3859
页数：1
相关论文
共 50 条
  • [31] RECOMBINANT ALPHA-INTERFERON AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PIGNEUX, A
    REIFFERS, J
    DEVERGIE, A
    LAFAGE, M
    RIO, B
    ARCHIMBAUD, E
    CAHN, JY
    LEBLOND, V
    MICHALLET, M
    GUILHOT, F
    GLUCKMAN, E
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1019 - 1019
  • [32] Effect of interferon-alpha (IFN) on outcome of unrelated donor (URD) bone marrow transplantation (BMT).
    Lee, SJ
    Klein, JP
    Anasetti, C
    Antin, JH
    Loberiza, F
    Matlack, M
    Horowitz, MR
    Giralt, S
    BLOOD, 2000, 96 (11) : 841A - 841A
  • [33] Monitoring the effect of allogeneic bone marrow transplantation (BMT) and of alpha-interferon (IFN) in chronic myeloid leukemia. A national prospective study in Italy.
    Tura, S
    BLOOD, 1996, 88 (10) : 2717 - 2717
  • [34] Favourable survival of allogeneic stem cell transplantation after prior cytogenetic response to IFN in chronic myelogenous leukemia (CML).
    Reiter, A
    Maywald, O
    Metzgeroth, G
    Berger, U
    Hochhaus, A
    Pfirrmann, M
    Gnad, SU
    Kolb, HJ
    Gratwohl, A
    Bunjes, D
    Schaefer, UW
    Zander, AR
    Finke, J
    Arnold, R
    Fauser, AA
    Schwerdtfeger, R
    Sahakyan, L
    Hasford, J
    Hehlmann, R
    BLOOD, 2002, 100 (11) : 323B - 323B
  • [35] Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia
    M Wilhelm
    C Bueso-Ramos
    S O’Brien
    S Pierce
    M Keating
    M Talpaz
    HM Kantarjian
    Leukemia, 1998, 12 : 65 - 70
  • [36] Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia
    Wilhelm, M
    Bueso-Ramos, C
    O'Brien, S
    Pierce, S
    Keating, M
    Talpaz, M
    Kantarjian, HM
    LEUKEMIA, 1998, 12 (01) : 65 - 70
  • [37] ALPHA-INTERFERON (IFN) RESULTS IN HIGH COMPLETE CYTOGENETIC RESPONSE RATE IN PATIENTS WITH CYTOGENETIC-ONLY RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER MARROW TRANSPLANTATION (BMT)
    HIGANO, C
    RASKIND, W
    FLOWERS, M
    BLOOD, 1993, 82 (10) : A169 - A169
  • [38] Outcome of Chinese patients with chronic myeloid leukaemia (CML) underwent allogeneic bone-marrow transplantation (BMT)
    Lee, CK
    Lie, AKW
    Liang, R
    Au, WY
    Chen, FE
    Chim, CS
    Kwong, YL
    AMERICAN JOURNAL OF HEMATOLOGY, 1999, 61 (02) : 85 - 89
  • [39] USE OF ALPHA-INTERFERON FOR THE TREATMENT OF RELAPSE OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    HIGANO, CS
    RASKIND, WH
    SINGER, JW
    BLOOD, 1992, 80 (06) : 1437 - 1442
  • [40] Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation
    J L Steegmann
    L F Casado
    J F Tomás
    C Sanz-Rodríguez
    E Granados
    R de la Cámara
    A Alegre
    L Vázquez
    M T Ferro
    A Figuera
    R Arranz
    J M Fernández-Rañada
    Bone Marrow Transplantation, 1999, 23 : 483 - 488
12345